CAPTRUST FINANCIAL ADVISORS - VISTAGEN THERAPEUTICS INC ownership

VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 105 filers reported holding VISTAGEN THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 12.86 and the average weighting 0.3%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of VISTAGEN THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$13,616
-14.9%
109,190
+4.0%
0.00%
Q3 2022$16,000
+300.0%
105,000
+2000.0%
0.00%
Q2 2022$4,000
-33.3%
5,0000.0%0.00%
Q1 2022$6,000
-76.9%
5,000
-62.3%
0.00%
Q4 2021$26,000
+73.3%
13,265
+147.9%
0.00%
Q3 2021$15,000
-6.2%
5,351
+7.0%
0.00%
Q2 2021$16,0005,0000.00%
Other shareholders
VISTAGEN THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Henrickson Nauta Wealth Advisors, Inc. 200,000$24,9400.02%
GSA CAPITAL PARTNERS LLP 1,275,215$1590.02%
TKG Advisors, LLC 134,860$16,8170.01%
JOHNSON & JOHNSON 190,494$23,7550.01%
GPS Wealth Strategies Group, LLC 253,205$31,5750.01%
Performa Ltd (US), LLC 90,000$11,2230.01%
Jackson Wealth Management, LLC 23,850$2,9740.00%
Garden State Investment Advisory Services LLC 30,000$3,7410.00%
MAI Capital Management 584,925$72,9400.00%
Twin Lakes Capital Management, LLC 12,500$1,5590.00%
View complete list of VISTAGEN THERAPEUTICS INC shareholders